PPAR activators and gastroenterology.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D003424:Crohn Disease / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000378:metabolism; D047495:PPAR gamma / Q000819:agonists / Q000187:drug effects / Q000502:physiology; D015230:Prostaglandin D2 / Q000031:analogs & derivatives* / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use
D000970:Antineoplastic Agents; D047495:PPAR gamma; D045162:Thiazolidinediones; C037112:9-deoxy-delta-9-prostaglandin D2; D015230:Prostaglandin D2